TITLE

Monocyte-Derived Dendritic Cells from HIV Type 1—Infected Individuals Show Reduced Ability to Stimulate T Cells and Have Altered Production of Interleukin (IL)—12 and IL-10

AUTHOR(S)
Buisson, Sandrine; Benlahrech, Adel; Gazzard, Brian; Gotch, Frances; Kelleher, Peter; Patterson, Steven
PUB. DATE
June 2009
SOURCE
Journal of Infectious Diseases;6/15/2009, Vol. 199 Issue 12, p1862
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Monocyte-derived dendritic cells (MDDCs) have been used in therapeutic vaccination for cancer.Asmall number of studies have employed a similar approach to vaccinate human immunodeficiency virus (HIV)-infected individuals. We have thus analyzed the functional properties of MDDCs generated from HIV-infected individuals who either are receiving highly active antiretroviral therapy or are therapy naive. There was no difference in the MDDC phenotype or efficiency of MDDC generation between HIV-infected individuals and healthy control subjects. Despite this, the MDDCs derived from both groups of infected individuals were severely impaired in their ability to stimulate the proliferation of allogeneic T cells. Furthermore, production of interferon-γ was reduced in Tcells stimulated by MDDCs. These functional changesmaybe at least partly explained by reduced interleukin-12 and increased interleukin-10 secretion on stimulation with lipopolysaccharide and CD40 ligand. Our findings suggest that MDDCs used in therapeutic vaccination of HIV-infected individuals may show reduced potency.
ACCESSION #
41534721

 

Related Articles

  • Human Immunodeficiency Virus Interactions with CD8+ T Lymphocytes. Saksena, Nitin K.; Jing Qin Wu; Potter, Simon J.; Wilkinson, John; Bin Wang // Current HIV Research;Jan2008, Vol. 6 Issue 1, p1 

    Human immunodeficiency virus (HIV)-specific CD8+ T cells can mediate anti-HIV activity by both cytolytic (cytotoxic T lymphocyte or CTL) and non-cytolytic mechanisms (antiviral) and play a crucial role in HIV pathogenesis. Both mechanisms actively contribute to the control of HIV in vivo. The...

  • Engineering T Cells to Functionally Cure HIV-1 Infection. Leibman, Rachel S; Riley, James L // Molecular Therapy;Jul2015, Vol. 23 Issue 7, p1149 

    Despite the ability of antiretroviral therapy to minimize human immunodeficiency virus type 1 (HIV-1) replication and increase the duration and quality of patients' lives, the health consequences and financial burden associated with the lifelong treatment regimen render a permanent cure highly...

  • Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells. Tzu-Ling Sung; Rice, Andrew P. // Retrovirology;2006, Vol. 3, p1 

    Background: The latent reservoir of human immunodeficiency virus type 1 (HIV-1) in resting CD4+ T cells is a major obstacle to the clearance of infection by highly active antiretroviral therapy (HAART). Recent studies have focused on searches for adjuvant therapies to activate this reservoir...

  • Expanded Cytotoxic T-cell Lymphocytes Target the Latent HIV Reservoir. Sung, Julia A.; Lam, Sharon; Garrido, Carolina; Archin, Nancie; Rooney, Cliona M.; Bollard, Catherine M.; Margolis, David M. // Journal of Infectious Diseases;7/15/2015, Vol. 212 Issue 2, p258 

    Enhanced human immunodeficiency virus (HIV)-specific immunity may be required for HIV eradication. Administration of autologous, ex vivo expanded, virus-specific, cytotoxic T-lymphocytes derived from HIV-infected patients on suppressive antiretroviral therapy (HXTCs) are a powerful tool for...

  • Rapid Turnover of 2-LTR HIV-1 DNA during Early Stage of Highly Active Antiretroviral Therapy. Zhu, Weijun; Jiao, Yanmei; Lei, Rongyue; Hua, Wei; Wang, Rui; Ji, Yunxia; Liu, Zhiying; Wei, Feili; Zhang, Tong; Shi, Xuanlin; Wu, Hao; Zhang, Linqi // PLoS ONE;2011, Vol. 6 Issue 6, p1 

    Background: Despite prolonged treatment with highly active antiretroviral therapy (HAART), the infectious HIV-1 continues to replicate and resides latently in the resting memory CD4+ T lymphocytes, which blocks the eradication of HIV-1. The viral persistence of HIV-1 is mainly caused by its...

  • A therapeutic vaccine candidate briefly controls viral load. McEnery, Regina // VAX;Jan2013, Vol. 11 Issue 1, p3 

    The article presents information on a study conducted by a team of researchers from Spain, in which they found that a therapeutic AIDS vaccine candidate allowed freedom to some HIV-infected persons from combination antiretroviral therapy (cART), but for a short period. To make the vaccine...

  • Human Immunodeficiency Virus (HIV-1) reverse transcriptase inhibitory activity of Phyllanthus emblica plant extract. Estari, M.; Venkanna, L.; Sripriya, D.; Lalitha, R. // Biology & Medicine;Oct-Dec2012, Vol. 4 Issue 4, p178 

    Human Immunodeficiency Virus type-1 (HIV-1) is the cause of Acquired Immune Deficiency Syndrome (AIDS), a major human viral disease with about 33.2 million people infected worldwide. The high cost of the HAART regimen has impeded its delivery to over 90% of the HIV/AIDS population in the world....

  • Characterization of Proviral HIV Latency in Different T Cell Subsets of Patients Undergoing HAART. Chaudhary, Suman; Lopez, Pablo; Rodriguez, Nayra; Kumar, Anil; Yamamura, Yasuhiro // Retrovirology;2005 Supplement 1, Vol. 2, pP151 

    The article presents a study on the characterization of proviral human immunodeficiency virus (HIV) latency in different T cell subsets. Peripheral blood were obtained from five HIV patients, who receive highly active antiretroviral therapy (HAART). It reveals that proviral HIV DNA in each T...

  • highly active antiretroviral therapy (HAART):. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p108 

    An encyclopedia entry for "highly active antiretroviral therapy" is presented. This therapy refers to a powerful combination of drugs, which renders human immunodeficiency viruses undetectable in the body of an infected person. This therapy contains one drug that is usually an HIV protease...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics